ProQR Therapeutics N.V. (NASDAQ: PRQR)
$3.6100
N/A ( +0.28% ) 199.4K
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.